Positive Developments in Risperdal Litigation in August
Several positive developments this month for young men injured from taking the Risperdal. Risperdal is an anti-psychotic drug manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals. The drug’s side effects included gynecomastia, the growth of female-like breast in young boys. $2.5M Jury Verdict Stands The Supreme Court of Pennsylvania has declined to hear an appeal of […]
Judge Proceeds with Risperdal Punitive Damages Trial
Philadelphia Court of Common Pleas Judge Arnold L. New has ordered two Risperdal cases to proceed in a new trial for punitive damages. In both cases, causation and compensatory damage were already awarded the plaintiffs– Stange v. Janssen Pharmaceuticals ($500,000) and Murray v. Janssen Pharmaceuticals ($1.75M later reduced to $680,000). Judge New previously ruled in agreement […]
